4568
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Daiichi Sankyo Company, Limited is a pharmaceutical company engaged in the research, development, manufacturing, and sales of prescription and over-the-counter medicines. The group operates through a single reporting segment and includes subsidiaries such as Daiichi Sankyo Healthcare for consumer health products, Daiichi Sankyo Biotech for vaccine development, and Daiichi Sankyo U.S. Holdings Inc. for North American operations. In Europe, Daiichi Sankyo Europe GmbH manages regional activities, while subsidiaries in China and Brazil handle local manufacturing and sales. The company supplies intermediates and finished products to its international affiliates and outsources research and development tasks to entities like American Regent Inc. and Daiichi Sankyo Inc.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage daiichisankyo.com
Sector Healthcare IR page daiichisankyo.com
Tags
oncology, cardiovascular, vaccines, consumer health, prescription drugs, over-the-counter medicines, biotechnology, pharmaceutical manufacturing, pharmaceutical sales, Daiichi Sankyo Healthcare, Daiichi Sankyo Biotech, Daiichi Sankyo Business Associates, Daiichi Sankyo U.S. Holdings Inc., Daiichi Sankyo Inc., American Regent Inc., Daiichi Sankyo Europe GmbH, Daiichi Sankyo (China) Investment Co. Ltd., Daiichi Sankyo Pharmaceutical (Shanghai) Co. Ltd., Daiichi Sankyo Brazil Ltda.
Press page —

Metrics

Valuation  
Market cap ¥ 5.187T
Market cap (USD) $ 32.421B
P/E 17.00
PEG 0.46
P/BV 2.91
P/S 2.24
P/OCF 33.10
P/FCF 155.02
Dividend yield 2.8%
Turnover / mcap —
Returns  
ROE 16.9%
ROI 16.6%
ROIC 14.7%
Profit margin 13.2%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 36.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score 26.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 2.123T 1.886T 1.602T 1.278T 1.045T 962.516B 981.793B 929.717B 960.195B 955.124B 986.446B 919.372B 1.119T 997.852B
Net profit 279.728B 295.756B 200.731B 109.188B 66.972B 75.958B 129.074B 93.409B 60.282B 53.466B 82.282B 322.119B 65.65B 66.621B
Free cash flow -50.71B -134.03B 476.467B 47.148B 62.544B 128.114B 164.665B 25.42B — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 2.761K 3.512K 4.773K 4.824K 2.68K 3.224K 7.428K 5.098K 3.525K 2.508K 2.504K 1.908K 1.74K 1.818K
Price performance 12m -0.21 -0.26 -0.01 0.8 -0.17 -0.57 0.46 0.45 0.41 0 0.31 0.1 -0.04 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) — 232B 420B 309B 232B 267B 349B 454B 619B 741B
↳ YoY growth +81.2% -26.3% -25.0% +14.9% +30.9% +30.1% +36.3% +19.7%
↳ 5y CAGR +8.6% +1.6% +14.9% +26.1%
Borrowings, current (JPY) — 20B 40B 40.4B 20.4B 20.4B 41.4B 399M 399M 404M
Borrowings, non-current (JPY) — 261B 221B 184B 163B 143B 102B 101B 101B 300B
Cash and deposits (JPY) 246B 358B 243B 424B 381B 662B 442B 647B 640B 450B
Intangible assets (JPY) — 174B 169B 172B 173B 164B 160B 168B 236B 241B
Net debt (borrowings + leases - cash) (JPY) — -77.1B 17.4B -200B -197B -499B -299B -545B -539B -149B
Cash flow detail
Operating cash flow (JPY) 136B 108B 92B 197B 192B 139B 115B 599B 53.8B 77.7B
Purchases of property, plant and equipment (JPY) — -23.4B -36.1B -31.9B -31.2B -62.7B -60.7B -88.3B -116B -128B
Purchases of intangible assets (JPY) — -14.6B -30.5B -20.6B -32.8B -13.9B -6.62B -34.5B -71.6B -20.6B
Change in receivables (cash effect) (JPY) — 2.54B -188B 110B 83.1B -19.1B -64.6B -69.9B -168B -105B
Change in inventories (cash effect) (JPY) — -19.4B -4.02B -7.39B -21.2B -603M -80.7B -129B -78.4B -173B
Change in payables (cash effect) (JPY) — 238M 60.4B -44.7B 23.9B 13.3B 54.1B 120B 40.1B -10.5B
Dividends paid (cash effect) (JPY) — -46.4B -45.3B -45.4B -48.9B -51.7B -54.6B -67.1B -114B -128B
Share buybacks (cash effect) (JPY) — -50.1B -45M -85M -100B -15M -24M -25M -246B -150B
Interest paid (cash effect) (JPY) — -2.04B -1.77B -2.53B -1.84B -1.78B -2.08B -1.84B -1.93B -2.24B
Operating cash flow before change in receivables (JPY) — 106B 280B 86.4B 109B 158B 179B 669B 222B 182B
Free cash flow (OCF - PPE - intangibles) (JPY) — 70.4B 25.4B 144B 128B 62.5B 47.1B 476B -134B -71.3B
Income detail
Research and development expense (JPY) — 236B 204B 198B 227B 260B 342B 365B 436B 466B
↳ 5y CAGR +7.7% +12.4% +17.2% +15.4%
Total comprehensive income (JPY) — 61.9B 164B 102B 115B 130B 149B 308B 290B 310B
Comprehensive income to owners (JPY) 38.3B 62.4B 164B 102B 115B 130B 149B 308B 290B 310B
Reported Jun 19, 2017 Jun 17, 2019 Jun 17, 2019 Jun 15, 2020 Jun 21, 2021 Jun 27, 2022 Jun 19, 2023 Jun 17, 2024 Jun 20, 2025 Jun 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2026年度 第2四半期決算説明会資料 Bull 3 Bear 0 Results

Prompts

Daiichi Sankyo Company, Limited (ticker 4568), listed in Japan.

ETFs Holding Daiichi Sankyo Company, Limited

ETF Weight in ETF Shares Market value As of
DTAN 0.97% 12,100 $ 211.102K Nov 17, 2026
TDI 0.44% 99,201 $ 1.591M Jun 30, 2026
UMMA 0.31% 51,897 $ 925.531K Aug 31, 2026
IVSI 0.15% 744 $ 11.936K Jun 30, 2026
NTSI 0.14% 42,200 $ 677.303K Jun 30, 2026
DFAI 0.06% 628,400 $ 11.23M Nov 12, 2026
DFIC 0.04% 356,000 $ 6.362M Nov 12, 2026
DFSI 0.04% 27,048 $ 483.362K Nov 12, 2026
AVSD 0.04% 8,600 $ 154.161K Nov 16, 2026
DFAX 0.03% 214,100 $ 3.826M Nov 12, 2026
AVDE 0.03% 287,600 $ 5.155M Nov 16, 2026
JSTC 0.02% 3,573 $ 64.261K Nov 17, 2026
DXIV 0.02% 2,200 $ 39.315K Nov 12, 2026